254 related articles for article (PubMed ID: 10605693)
1. Benign, preinvasive and invasive ductal breast lesions. A comparative study with quantitative techniques: morphometry, image- and flow cytometry.
Ruiz A; Almenar S; Callaghan RC; Llombart-Bosch A
Pathol Res Pract; 1999; 195(11):741-6. PubMed ID: 10605693
[TBL] [Abstract][Full Text] [Related]
2. Nuclear cytometric changes in breast carcinogenesis.
Mommers EC; Poulin N; Sangulin J; Meijer CJ; Baak JP; van Diest PJ
J Pathol; 2001 Jan; 193(1):33-9. PubMed ID: 11169513
[TBL] [Abstract][Full Text] [Related]
3. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric DNA analysis of breast cancers with predominance of carcinoma in situ: a comparison of the premalignant and malignant components.
Ottesen GL; Christensen IJ; Larsen JK; Hansen B; Andersen AJ
Clin Cancer Res; 1995 Aug; 1(8):881-8. PubMed ID: 9816058
[TBL] [Abstract][Full Text] [Related]
5. Flat epithelial atypia and atypical ductal hyperplasia: carcinoma underestimation rate.
Ingegnoli A; d'Aloia C; Frattaruolo A; Pallavera L; Martella E; Crisi G; Zompatori M
Breast J; 2010; 16(1):55-9. PubMed ID: 19825003
[TBL] [Abstract][Full Text] [Related]
6. Expression of centrosomal tubulins associated with DNA ploidy in breast premalignant lesions and carcinoma.
Niu Y; Wang S; Liu T; Zhang T; Wei X; Wang Y; Jiang L
Pathol Res Pract; 2013 Apr; 209(4):221-7. PubMed ID: 23523041
[TBL] [Abstract][Full Text] [Related]
7. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
[TBL] [Abstract][Full Text] [Related]
8. Quantitative study of ductal breast cancer progression: signatures of nuclei in proliferating breast lesions and in situ cancer.
Mariuzzi L; Mombello A; Rucco V; Morelli L; Zamò A; Thompson D; Vaught L; Bartels HG; Mariuzzi G; Bartels PH
Adv Clin Path; 2000 Apr; 4(2):87-97. PubMed ID: 11080789
[TBL] [Abstract][Full Text] [Related]
9. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma.
Chen TL; Luo I; Mikhail N; Rasková J; Raska K
Cytometry; 1995 Sep; 22(3):181-9. PubMed ID: 8556949
[TBL] [Abstract][Full Text] [Related]
10. Quantitative study of ductal breast cancer progression. Morphometric evaluation of phenotypical changes occurring in benign and preinvasive epithelial lesions.
Mariuzzi GM; Mariuzzi L; Mombello A; Santinelli A; Valli M; Rahal D; Thompson D; Bartels PH
Pathol Res Pract; 1994 Nov; 190(11):1056-65. PubMed ID: 7746739
[TBL] [Abstract][Full Text] [Related]
11. Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.
Poller DN; Silverstein MJ; Galea M; Locker AP; Elston CW; Blamey RW; Ellis IO
Mod Pathol; 1994 Feb; 7(2):257-62. PubMed ID: 7911998
[TBL] [Abstract][Full Text] [Related]
12. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.
Xu S; Wei B; Zhang H; Qing M; Bu H
Oncol Rep; 2008 Jun; 19(6):1469-75. PubMed ID: 18497952
[TBL] [Abstract][Full Text] [Related]
13. DNA analysis of in situ ductal carcinoma of the breast via flow cytometry.
Ottesen GL; Christensen IJ; Larsen JK; Christiansen J; Hansen B; Andersen JA
Cytometry; 1995 Sep; 22(3):168-76. PubMed ID: 8556947
[TBL] [Abstract][Full Text] [Related]
14. [Classification of preinvasive breast and carcinoma in situ: doubts, controversies, and proposal for new categorizations].
Dauplat MM; Penault-Llorca F
Bull Cancer; 2004 Dec; 91 Suppl 4():S205-10. PubMed ID: 15899609
[TBL] [Abstract][Full Text] [Related]
15. Ductal carcinoma in situ of the breast: a comparative analysis of histology, nuclear area, ploidy, and neovascularization provides differentiation between low- and high-grade tumors.
Ruiz A; Almenar S; Cerdá M; Hidalgo JJ; Puchades A; Llombart-Bosch A
Breast J; 2002; 8(3):139-44. PubMed ID: 12047469
[TBL] [Abstract][Full Text] [Related]
16. DNA ploidy analysis in breast carcinoma. Comparison of unfixed and fixed tissue analyzed by image and flow cytometry.
Ottesen GL; Christensen IJ; Larsen JK; Larsen J; Christiansen J; Baldetorp B; Linden T; Hansen B; Andersen JA
Anal Quant Cytol Histol; 1997 Oct; 19(5):413-22. PubMed ID: 9349901
[TBL] [Abstract][Full Text] [Related]
17. bcl-2 expression in the spectrum of preinvasive breast lesions.
Siziopikou KP; Prioleau JE; Harris JR; Schnitt SJ
Cancer; 1996 Feb; 77(3):499-506. PubMed ID: 8630957
[TBL] [Abstract][Full Text] [Related]
18. Differences in quantitative nuclear features between ductal carcinoma in situ (DCIS) with and without accompanying invasive carcinoma in the surrounding breast.
Susnik B; Worth A; Palcic B; Poulin N; LeRiche J
Anal Cell Pathol; 1995 Jan; 8(1):39-52. PubMed ID: 7734410
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis and VEGF expression in pre-invasive lesions of the human breast.
Viacava P; Naccarato AG; Bocci G; Fanelli G; Aretini P; Lonobile A; Evangelista G; Montruccoli G; Bevilacqua G
J Pathol; 2004 Oct; 204(2):140-6. PubMed ID: 15376259
[TBL] [Abstract][Full Text] [Related]
20. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K
Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
